This Healthcare Stock Is Sending More Cash to Its Shareholders: Should You Buy It?
The primary objective of dividend growth investing is to build an investment portfolio that can provide an investor with reliable and growing streams of passive income. The dividends can be used however the investor would like -- paying bills, saving in the bank, or reinvesting in more shares.
Medical devices maker (NYSE: SYK) is an excellent dividend growth stock. This is evidenced by the fact that its dividend, payable on July 31, will be 7.9% higher compared to the previous year. But is the stock a buy for dividend growth investors?
Let's analyze Stryker's fundamentals and valuation to get an answer.
Source Fool.com
Stryker Corp. Aktie
323,90 €
0,59 %
Stryker Corp. als klarer Gewinner: Nur Buy-Einschätzungen, keine Sell-Einschätzungen.
Ein Kursziel von 340 € für Stryker Corp. zeigt ein leicht positives Potenzial im Vergleich zum aktuellen Kurs von 323.9 €.
